Research programme: mescaline derivatives - Enveric Biosciences
Alternative Names: EVM 401 series; EVM-401Latest Information Update: 15 Apr 2025
At a glance
- Originator MagicMed Industries
- Developer Enveric Biosciences
- Class Alkaloids; Antipsychotics; Neuropsychotherapeutics; Phenethylamines; Phenyl ethers
- Mechanism of Action Serotonin 5-HT2 receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes
Highest Development Phases
- Research Mental disorders; Neurological disorders
Most Recent Events
- 31 Mar 2025 EVM-401 series of compounds are still in early research for Neurological disorders and Mental disorders in Canada
- 28 Jan 2025 No recent reports of development identified for research development in Mental-disorders in Canada
- 28 Jan 2025 No recent reports of development identified for research development in Neurological-disorders in Canada